Biomedical Engineering Reference
In-Depth Information
Figure 2.2
PHA production at pathways proposed for
C. necator
: (I) balanced growth for biomass production; (II) unbalanced growth for P(3HB) (a PHAS
SCL
)
production; (III) P(3HB-
co
-3HV) production from propionigenic substrates by
C. necator
, and proposed for pseudomonads; (IV) PHA
MCL
or PHAS
SCL
production
from fatty acids
de novo
synthesis; and (V) PHA
MCL
production from fatty acids
β
- oxidation (based on [83] with modifi cations).
